IART - Company ID 0000917520
The table below shows INTEGRA LIFESCIENCES HOLDINGS CORP's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $235.05M | $246.38M | $276.40M | $456.66M | $513.45M | $470.17M |
| Short-term investments | $28.69M | $27.19M | $32.69M | - | - | - |
| Receivables | $278.85M | $272.37M | $259.33M | $263.46M | $231.83M | $225.53M |
| Inventory | $492.74M | $429.09M | $389.61M | $324.58M | $317.39M | $310.12M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.16B |
| $1.08B |
| $1.06B |
| $1.16B |
| $1.15B |
| $1.24B |
| Property, plant & equipment | $444.33M | $405.72M | $340.20M | $311.30M | $311.70M | $287.53M |
| Goodwill | $615.16M | $1.10B | $1.06B | $1.04B | $1.01B | $932.37M |
| Total assets | $3.60B | $4.04B | $3.78B | $3.89B | $3.78B | $3.62B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $455.98M | $922.13M | $306.98M | $320.91M | $340.02M | $401.01M |
| Long-term debt | $726.56M | $760.47M | $775.00M | $775.00M | $843.75M | $877.50M |
| Total liabilities | $2.56B | $2.49B | $2.19B | $2.09B | $2.10B | $2.10B |
| Retained earnings | $423.44M | $939.91M | $946.86M | $879.12M | $698.57M | $532.26M |
| Total equity | $1.04B | $1.55B | $1.59B | $1.80B | $1.68B | $1.51B |